Jason N. Butler
Stock Analyst at Citizens
(2.12)
# 1,004
Out of 5,152 analysts
15
Total ratings
46.67%
Success rate
-1.53%
Average return
Main Sectors:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Market Outperform | $925 → $944 | $728.11 | +29.65% | 1 | Feb 27, 2026 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Market Outperform | $8 → $10 | $3.62 | +176.24% | 1 | Feb 26, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $34 → $35 | $22.40 | +56.25% | 3 | Feb 26, 2026 | |
| ACHV Achieve Life Sciences | Initiates: Market Outperform | $19 | $4.40 | +331.82% | 1 | Nov 25, 2025 | |
| RAPP Rapport Therapeutics | Maintains: Market Outperform | $77 → $80 | $29.65 | +169.81% | 1 | Nov 7, 2025 | |
| WULF TeraWulf | Maintains: Market Outperform | $18 → $22 | $15.23 | +44.45% | 1 | Oct 29, 2025 | |
| RZLT Rezolute | Maintains: Market Outperform | $9 → $17 | $3.13 | +443.13% | 1 | Oct 29, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Market Outperform | $95 → $114 | $112.70 | +1.15% | 1 | Sep 25, 2025 | |
| CRMD CorMedix | Reiterates: Market Outperform | $22 | $6.30 | +249.21% | 1 | Sep 9, 2025 | |
| CYTK Cytokinetics | Reiterates: Market Outperform | $78 | $62.19 | +25.42% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $6 → $8 | $3.37 | +137.39% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $19 → $18 | $8.79 | +104.78% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $91 → $78 | $67.36 | +15.80% | 1 | Aug 6, 2025 |
argenx SE
Feb 27, 2026
Maintains: Market Outperform
Price Target: $925 → $944
Current: $728.11
Upside: +29.65%
Ironwood Pharmaceuticals
Feb 26, 2026
Maintains: Market Outperform
Price Target: $8 → $10
Current: $3.62
Upside: +176.24%
ACADIA Pharmaceuticals
Feb 26, 2026
Maintains: Market Outperform
Price Target: $34 → $35
Current: $22.40
Upside: +56.25%
Achieve Life Sciences
Nov 25, 2025
Initiates: Market Outperform
Price Target: $19
Current: $4.40
Upside: +331.82%
Rapport Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $77 → $80
Current: $29.65
Upside: +169.81%
TeraWulf
Oct 29, 2025
Maintains: Market Outperform
Price Target: $18 → $22
Current: $15.23
Upside: +44.45%
Rezolute
Oct 29, 2025
Maintains: Market Outperform
Price Target: $9 → $17
Current: $3.13
Upside: +443.13%
ABIVAX Société Anonyme
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $112.70
Upside: +1.15%
CorMedix
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $6.30
Upside: +249.21%
Cytokinetics
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $62.19
Upside: +25.42%
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $3.37
Upside: +137.39%
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $8.79
Upside: +104.78%
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $67.36
Upside: +15.80%